News Conference News EuroPCR 2025 Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI Michael O'Riordan May 20, 2025
News Conference News EuroPCR 2022 Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot Michael O'Riordan May 23, 2022
News Conference News EuroPCR 2021 Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate Caitlin E. Cox May 24, 2021
News Conference News EuroPCR 2021 Elective Revascularization, Better Long-term Survival: Meta-analysis Michael O'Riordan May 18, 2021
News Conference News EuroPCR 2019 Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years Michael O'Riordan May 27, 2019
News Conference News EuroPCR 2019 Long-term Ticagrelor Monotherapy May Have an Edge in Complex PCI Patients: GLOBAL LEADERS Michael O'Riordan May 21, 2019
News Conference News EuroPCR 2018 ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics Michael O'Riordan May 31, 2018
News Conference News EuroPCR 2018 DCBs for CAD in Certain Patients With Large Vessel De Novo Disease? DEBUT Says Yes Caitlin E. Cox May 25, 2018
News Conference News EuroPCR 2018 FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis Michael O'Riordan May 22, 2018
News Conference News EuroPCR 2015 Trials Explore the Potential of Biodegradable-Polymer Stents Caitlin E. Cox May 21, 2015
News Conference News EuroPCR 2012 EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage Caitlin E. Cox May 22, 2012
News Conference News EuroPCR 2012 No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES Caitlin E. Cox May 18, 2012